Immunotherapy in metastatic renal cell carcinoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://link.springer.com/content/pdf/10.1007/s00345-004-0470-4.pdf
Reference60 articles.
1. Ljungberg B (2004) Prognostic factors in renal cell carcinoma. Urologe A. 43 [Suppl 3]:119–120
2. Pisani P, Parkin DM, Ferlay J (1993) Estimates of the worldwide mortality from eighteen major cancers in 1985: implications for prevention and projections of future burden. Int J Cancer 55:891
3. Landis SH, Murray T, Bolden S, Wingo PA (1998) Cancer statistics, 1998. Cancer J Clin 48:6–29
4. Pantuck AJ, Zisman A, Belldegrun AS (2001) The changing natural history of renal cell carcinoma. J Urol 166:1611–1623
5. De Kernion JB, Ramming KP, Smith RB (1978) The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol 120:148–52
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy of Sunitinib in Patients With Favorable and Intermediate Risk Metastatic Renal Cell Carcinoma – Lithuanian National Cancer Institute Experience;Anticancer Research;2023-12-30
2. Impact of tivozanib on patient outcomes in treatment of advanced renal cell carcinoma;Cancer Management and Research;2019-08
Impact of tivozanib on patient outcomes in treatment of advanced renal cell carcinoma
3. Sunitinib: Ten Years of Successful Clinical Use and Study in Advanced Renal Cell Carcinoma;The Oncologist;2017-01-01
4. Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action;Targeted Oncology;2016-11-15
5. Cancer Vaccines;Introduction to Molecular Vaccinology;2016
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3